Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Millipore, a life science company, has entered into an agreement to acquire Guava Technologies, a provider of cell analysis systems. The acquisition follows the distribution and co-development partnership the two companies announced in March 2008.
Subscribe to our email newsletter
Under the terms of the agreement, Millipore will pay $22.6 million, subject to closing adjustments, to acquire Guava. The transaction is expected to be slightly accretive to Millipore’s non-GAAP earnings per share during 2009 and is expected to close in the next two weeks.
Martin Madaus, chairman and CEO of Millipore, said: “The acquisition of Guava represents another step forward in the transformation of our bioscience division. Over the past three years, Millipore has become a life science leader with the product breadth and expertise to create platform solutions that enable our customers to work more efficiently.
“With the Guava acquisition, we will bring the power of our flow cytometry platform to all cell biologists by combining Guava’s instruments with our broad range of fully-validated reagent kits.”